| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 7.63e-07 | 120 | 29 | 5 | GO:0004222 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 9.36e-06 | 200 | 29 | 5 | GO:0008237 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 3.00e-05 | 430 | 29 | 6 | GO:0004175 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.50e-04 | 188 | 29 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | heparin binding | 1.63e-04 | 192 | 29 | 4 | GO:0008201 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 1.87e-04 | 599 | 29 | 6 | GO:0050839 | |
| GeneOntologyMolecularFunction | peptidase activity | 3.01e-04 | 654 | 29 | 6 | GO:0008233 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 3.81e-04 | 20 | 29 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 5.79e-04 | 268 | 29 | 4 | GO:0005539 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 1.16e-03 | 323 | 29 | 4 | GO:1901681 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.86e-03 | 44 | 29 | 2 | GO:0140938 | |
| GeneOntologyMolecularFunction | integrin binding | 2.04e-03 | 175 | 29 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 4.37e-03 | 68 | 29 | 2 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 4.50e-03 | 69 | 29 | 2 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 4.76e-03 | 71 | 29 | 2 | GO:0042054 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 9.77e-03 | 103 | 29 | 2 | GO:0008276 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 1.01e-02 | 105 | 29 | 2 | GO:0008170 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.04e-05 | 566 | 29 | 7 | GO:0007409 | |
| GeneOntologyBiologicalProcess | axon development | 2.35e-05 | 642 | 29 | 7 | GO:0061564 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 2.76e-05 | 42 | 29 | 3 | GO:0099560 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 6.23e-05 | 748 | 29 | 7 | GO:0048667 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 6.86e-05 | 313 | 29 | 5 | GO:0098742 | |
| GeneOntologyBiologicalProcess | regulation of neuron migration | 8.94e-05 | 62 | 29 | 3 | GO:2001222 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 9.65e-05 | 802 | 29 | 7 | GO:0048812 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 1.10e-04 | 819 | 29 | 7 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 1.16e-04 | 826 | 29 | 7 | GO:0048858 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.72e-04 | 14 | 29 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection arborization | 1.98e-04 | 15 | 29 | 2 | GO:0150011 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 4.74e-04 | 23 | 29 | 2 | GO:2001044 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 5.49e-04 | 273 | 29 | 4 | GO:0030323 | |
| GeneOntologyBiologicalProcess | circulatory system development | 6.37e-04 | 1442 | 29 | 8 | GO:0072359 | |
| GeneOntologyBiologicalProcess | neuron development | 7.01e-04 | 1463 | 29 | 8 | GO:0048666 | |
| GeneOntologyBiologicalProcess | regulation of vascular endothelial growth factor signaling pathway | 8.10e-04 | 30 | 29 | 2 | GO:1900746 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to vascular endothelial growth factor stimulus | 9.22e-04 | 32 | 29 | 2 | GO:1902547 | |
| GeneOntologyBiologicalProcess | positive regulation of sprouting angiogenesis | 9.81e-04 | 33 | 29 | 2 | GO:1903672 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | 9.89e-04 | 846 | 29 | 6 | GO:0120035 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 1.08e-03 | 1194 | 29 | 7 | GO:0000902 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | 1.10e-03 | 863 | 29 | 6 | GO:0031344 | |
| GeneOntologyBiologicalProcess | positive regulation of filopodium assembly | 1.17e-03 | 36 | 29 | 2 | GO:0051491 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | 1.19e-03 | 582 | 29 | 5 | GO:0044089 | |
| GeneOntologyBiologicalProcess | neuron projection arborization | 1.30e-03 | 38 | 29 | 2 | GO:0140058 | |
| GeneOntologyBiologicalProcess | peptide hormone processing | 1.51e-03 | 41 | 29 | 2 | GO:0016486 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 1.58e-03 | 927 | 29 | 6 | GO:0030155 | |
| GeneOntologyBiologicalProcess | regulation of presynapse assembly | 1.59e-03 | 42 | 29 | 2 | GO:1905606 | |
| GeneOntologyBiologicalProcess | neuron projection development | 1.66e-03 | 1285 | 29 | 7 | GO:0031175 | |
| GeneOntologyBiologicalProcess | kidney development | 1.73e-03 | 372 | 29 | 4 | GO:0001822 | |
| GeneOntologyBiologicalProcess | signaling receptor ligand precursor processing | 1.90e-03 | 46 | 29 | 2 | GO:0140448 | |
| GeneOntologyBiologicalProcess | regulation of presynapse organization | 1.90e-03 | 46 | 29 | 2 | GO:0099174 | |
| GeneOntologyBiologicalProcess | renal system development | 1.98e-03 | 386 | 29 | 4 | GO:0072001 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 6.22e-06 | 530 | 29 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.48e-05 | 656 | 29 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.53e-05 | 658 | 29 | 7 | GO:0030312 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 2.49e-04 | 17 | 29 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.13e-03 | 583 | 29 | 5 | GO:0097060 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 3.03e-03 | 59 | 29 | 2 | GO:0098636 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 5.23e-03 | 78 | 29 | 2 | GO:0048787 | |
| Domain | EGF-like_dom | TENM1 PCSK5 NTNG1 SLIT2 ADAM29 NTNG2 FBN1 MALRD1 DLL1 TENM2 ADAM22 TNN LAMA1 | 1.72e-17 | 249 | 29 | 13 | IPR000742 |
| Domain | EGF_1 | TENM1 NTNG1 SLIT2 ADAM29 NTNG2 FBN1 MALRD1 DLL1 SSPOP TENM2 ADAM22 TNN LAMA1 | 2.36e-17 | 255 | 29 | 13 | PS00022 |
| Domain | EGF_2 | TENM1 NTNG1 SLIT2 ADAM29 NTNG2 FBN1 MALRD1 DLL1 SSPOP TENM2 ADAM22 TNN LAMA1 | 3.90e-17 | 265 | 29 | 13 | PS01186 |
| Domain | EGF_3 | TENM1 NTNG1 SLIT2 ADAM29 NTNG2 FBN1 MALRD1 DLL1 SSPOP TENM2 ADAM22 TNN | 5.10e-16 | 235 | 29 | 12 | PS50026 |
| Domain | EGF | TENM1 PCSK5 NTNG1 SLIT2 NTNG2 FBN1 MALRD1 DLL1 TENM2 ADAM22 TNN LAMA1 | 5.10e-16 | 235 | 29 | 12 | SM00181 |
| Domain | EGF-like_CS | TENM1 NTNG1 SLIT2 ADAM29 NTNG2 FBN1 MALRD1 DLL1 TENM2 ADAM22 TNN LAMA1 | 1.81e-15 | 261 | 29 | 12 | IPR013032 |
| Domain | MetalloPept_cat_dom | 1.48e-07 | 81 | 29 | 5 | IPR024079 | |
| Domain | - | 1.48e-07 | 81 | 29 | 5 | 3.40.390.10 | |
| Domain | Peptidase_M12B_N | 3.71e-07 | 39 | 29 | 4 | IPR002870 | |
| Domain | Pep_M12B_propep | 3.71e-07 | 39 | 29 | 4 | PF01562 | |
| Domain | ZINC_PROTEASE | 3.86e-07 | 98 | 29 | 5 | PS00142 | |
| Domain | DISINTEGRIN_1 | 4.12e-07 | 40 | 29 | 4 | PS00427 | |
| Domain | ADAM_MEPRO | 4.12e-07 | 40 | 29 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 4.12e-07 | 40 | 29 | 4 | PS50214 | |
| Domain | Reprolysin | 4.12e-07 | 40 | 29 | 4 | PF01421 | |
| Domain | Peptidase_M12B | 4.12e-07 | 40 | 29 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 4.56e-07 | 41 | 29 | 4 | IPR001762 | |
| Domain | LAMININ_NTER | 1.86e-06 | 16 | 29 | 3 | PS51117 | |
| Domain | Laminin_N | 1.86e-06 | 16 | 29 | 3 | PF00055 | |
| Domain | Laminin_N | 1.86e-06 | 16 | 29 | 3 | IPR008211 | |
| Domain | LamNT | 1.86e-06 | 16 | 29 | 3 | SM00136 | |
| Domain | EGF_extracell | 2.15e-06 | 60 | 29 | 4 | IPR013111 | |
| Domain | EGF_2 | 2.15e-06 | 60 | 29 | 4 | PF07974 | |
| Domain | Growth_fac_rcpt_ | 3.85e-06 | 156 | 29 | 5 | IPR009030 | |
| Domain | DISIN | 4.39e-06 | 21 | 29 | 3 | SM00050 | |
| Domain | Disintegrin | 4.39e-06 | 21 | 29 | 3 | PF00200 | |
| Domain | Galactose-bd-like | 1.30e-05 | 94 | 29 | 4 | IPR008979 | |
| Domain | EGF_LAM_2 | 1.33e-05 | 30 | 29 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.33e-05 | 30 | 29 | 3 | PS01248 | |
| Domain | Tox-GHH_dom | 1.39e-05 | 4 | 29 | 2 | IPR028916 | |
| Domain | TENEURIN_N | 1.39e-05 | 4 | 29 | 2 | PS51361 | |
| Domain | Pecanex_C | 1.39e-05 | 4 | 29 | 2 | PF05041 | |
| Domain | Ten_N | 1.39e-05 | 4 | 29 | 2 | IPR009471 | |
| Domain | Pecanex | 1.39e-05 | 4 | 29 | 2 | IPR007735 | |
| Domain | Tox-GHH | 1.39e-05 | 4 | 29 | 2 | PF15636 | |
| Domain | Ten_N | 1.39e-05 | 4 | 29 | 2 | PF06484 | |
| Domain | Laminin_EGF | 2.13e-05 | 35 | 29 | 3 | PF00053 | |
| Domain | EGF_Lam | 2.13e-05 | 35 | 29 | 3 | SM00180 | |
| Domain | YD | 2.32e-05 | 5 | 29 | 2 | IPR006530 | |
| Domain | Laminin_EGF | 2.74e-05 | 38 | 29 | 3 | IPR002049 | |
| Domain | EGF_CA | 3.63e-05 | 122 | 29 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.87e-05 | 124 | 29 | 4 | IPR001881 | |
| Domain | EGF | 4.12e-05 | 126 | 29 | 4 | PF00008 | |
| Domain | Laminin_G_1 | 1.27e-04 | 11 | 29 | 2 | PF00054 | |
| Domain | NHL | 1.80e-04 | 13 | 29 | 2 | PS51125 | |
| Domain | - | 1.95e-04 | 73 | 29 | 3 | 2.60.120.260 | |
| Domain | Post-SET_dom | 2.76e-04 | 16 | 29 | 2 | IPR003616 | |
| Domain | PostSET | 2.76e-04 | 16 | 29 | 2 | SM00508 | |
| Domain | POST_SET | 2.76e-04 | 16 | 29 | 2 | PS50868 | |
| Domain | Disintegrin_CS | 2.76e-04 | 16 | 29 | 2 | IPR018358 | |
| Domain | ConA-like_dom | 3.47e-04 | 219 | 29 | 4 | IPR013320 | |
| Domain | CTCK_1 | 3.51e-04 | 18 | 29 | 2 | PS01185 | |
| Domain | ADAM_CR | 3.51e-04 | 18 | 29 | 2 | PF08516 | |
| Domain | PLAC | 3.92e-04 | 19 | 29 | 2 | IPR010909 | |
| Domain | PLAC | 3.92e-04 | 19 | 29 | 2 | PS50900 | |
| Domain | - | 4.23e-04 | 95 | 29 | 3 | 2.60.120.200 | |
| Domain | - | 4.35e-04 | 20 | 29 | 2 | 4.10.70.10 | |
| Domain | EGF_Ca-bd_CS | 4.50e-04 | 97 | 29 | 3 | IPR018097 | |
| Domain | EGF_CA | 4.78e-04 | 99 | 29 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 4.92e-04 | 100 | 29 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.83e-04 | 106 | 29 | 3 | IPR000152 | |
| Domain | Cys_knot_C | 6.83e-04 | 25 | 29 | 2 | IPR006207 | |
| Domain | CTCK_2 | 6.83e-04 | 25 | 29 | 2 | PS01225 | |
| Domain | ADAM_Cys-rich | 7.98e-04 | 27 | 29 | 2 | IPR006586 | |
| Domain | ACR | 7.98e-04 | 27 | 29 | 2 | SM00608 | |
| Domain | hEGF | 8.58e-04 | 28 | 29 | 2 | PF12661 | |
| Domain | Znf_RING | 1.53e-03 | 326 | 29 | 4 | IPR001841 | |
| Domain | LAM_G_DOMAIN | 1.58e-03 | 38 | 29 | 2 | PS50025 | |
| Domain | - | 1.66e-03 | 39 | 29 | 2 | 2.120.10.30 | |
| Domain | Laminin_G_2 | 1.75e-03 | 40 | 29 | 2 | PF02210 | |
| Domain | LDLR_class-A_CS | 1.75e-03 | 40 | 29 | 2 | IPR023415 | |
| Domain | SET | 1.84e-03 | 41 | 29 | 2 | PF00856 | |
| Domain | LamG | 2.11e-03 | 44 | 29 | 2 | SM00282 | |
| Domain | Ldl_recept_a | 2.21e-03 | 45 | 29 | 2 | PF00057 | |
| Domain | SET | 2.31e-03 | 46 | 29 | 2 | SM00317 | |
| Domain | - | 2.31e-03 | 46 | 29 | 2 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.31e-03 | 46 | 29 | 2 | IPR011042 | |
| Domain | LDLRA_1 | 2.51e-03 | 48 | 29 | 2 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 2.62e-03 | 49 | 29 | 2 | IPR002172 | |
| Domain | LDLa | 2.62e-03 | 49 | 29 | 2 | SM00192 | |
| Domain | LDLRA_2 | 2.62e-03 | 49 | 29 | 2 | PS50068 | |
| Domain | SET_dom | 2.72e-03 | 50 | 29 | 2 | IPR001214 | |
| Domain | SET | 2.72e-03 | 50 | 29 | 2 | PS50280 | |
| Domain | LRRNT | 3.05e-03 | 53 | 29 | 2 | PF01462 | |
| Domain | Laminin_G | 3.65e-03 | 58 | 29 | 2 | IPR001791 | |
| Domain | TSP_1 | 4.29e-03 | 63 | 29 | 2 | PF00090 | |
| Domain | Zinc_finger_PHD-type_CS | 4.56e-03 | 65 | 29 | 2 | IPR019786 | |
| Domain | TSP1 | 4.56e-03 | 65 | 29 | 2 | SM00209 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.84e-04 | 300 | 17 | 4 | M610 | |
| Pathway | PID_GLYPICAN_1PATHWAY | 4.72e-04 | 27 | 17 | 2 | M33 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 9.88e-04 | 39 | 17 | 2 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 9.88e-04 | 39 | 17 | 2 | MM15165 | |
| Pathway | REACTOME_KIDNEY_DEVELOPMENT | 1.37e-03 | 46 | 17 | 2 | M48243 | |
| Pathway | PID_PS1_PATHWAY | 1.37e-03 | 46 | 17 | 2 | M70 | |
| Pubmed | Association of polymorphisms in the SLIT2 axonal guidance gene with anger in suicide attempters. | 1.89e-07 | 14 | 29 | 3 | 20029409 | |
| Pubmed | Netrin-G2 dysfunction causes a Rett-like phenotype with areflexia. | 6.71e-07 | 2 | 29 | 2 | 31692205 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 15705354 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 26746425 | ||
| Pubmed | Laminets: laminin- and netrin-related genes expressed in distinct neuronal subsets. | 6.71e-07 | 2 | 29 | 2 | 11906208 | |
| Pubmed | Human netrin-G1 isoforms show evidence of differential expression. | 6.71e-07 | 2 | 29 | 2 | 15901489 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 17507910 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 9.91e-07 | 91 | 29 | 4 | 28558017 | |
| Pubmed | Synergistic integration of Netrin and ephrin axon guidance signals by spinal motor neurons. | 1.04e-06 | 24 | 29 | 3 | 26633881 | |
| Pubmed | 2.71e-06 | 117 | 29 | 4 | 17145500 | ||
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 4.02e-06 | 4 | 29 | 2 | 10225957 | |
| Pubmed | Identification of transcriptional regulatory elements for Ntng1 and Ntng2 genes in mice. | 4.02e-06 | 4 | 29 | 2 | 24642214 | |
| Pubmed | Netrin-G/NGL complexes encode functional synaptic diversification. | 4.02e-06 | 4 | 29 | 2 | 25411505 | |
| Pubmed | Axonal netrin-Gs transneuronally determine lamina-specific subdendritic segments. | 4.02e-06 | 4 | 29 | 2 | 17785411 | |
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 4.02e-06 | 4 | 29 | 2 | 12000766 | |
| Pubmed | Structural basis for cell surface patterning through NetrinG-NGL interactions. | 4.02e-06 | 4 | 29 | 2 | 21946559 | |
| Pubmed | Complementary expression and neurite outgrowth activity of netrin-G subfamily members. | 4.02e-06 | 4 | 29 | 2 | 11804778 | |
| Pubmed | 1.33e-05 | 175 | 29 | 4 | 28071719 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 12915301 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 10331952 | ||
| Pubmed | Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. | 1.87e-05 | 8 | 29 | 2 | 23055981 | |
| Pubmed | 2.10e-05 | 64 | 29 | 3 | 22261194 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 2.71e-05 | 1105 | 29 | 7 | 35748872 | |
| Pubmed | 2.87e-05 | 71 | 29 | 3 | 33541421 | ||
| Pubmed | Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma. | 3.01e-05 | 10 | 29 | 2 | 22421440 | |
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 38713721 | ||
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 9415455 | ||
| Pubmed | NGL family PSD-95-interacting adhesion molecules regulate excitatory synapse formation. | 4.41e-05 | 12 | 29 | 2 | 16980967 | |
| Pubmed | Dual role for LIM-homeodomain gene Lhx2 in the formation of the lateral olfactory tract. | 4.41e-05 | 12 | 29 | 2 | 17329426 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 5.21e-05 | 248 | 29 | 4 | 24006456 | |
| Pubmed | 5.46e-05 | 251 | 29 | 4 | 29031500 | ||
| Pubmed | NOVA2-mediated RNA regulation is required for axonal pathfinding during development. | 6.07e-05 | 14 | 29 | 2 | 27223325 | |
| Pubmed | 8.00e-05 | 16 | 29 | 2 | 30579834 | ||
| Pubmed | Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. | 8.00e-05 | 16 | 29 | 2 | 17229764 | |
| Pubmed | 9.06e-05 | 17 | 29 | 2 | 26102480 | ||
| Pubmed | In vivo visualization and molecular targeting of the cardiac conduction system. | 9.06e-05 | 17 | 29 | 2 | 35951416 | |
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 1.02e-04 | 18 | 29 | 2 | 39040056 | |
| Pubmed | 1.14e-04 | 19 | 29 | 2 | 25691540 | ||
| Pubmed | Evolution of Cortical Neurogenesis in Amniotes Controlled by Robo Signaling Levels. | 1.26e-04 | 20 | 29 | 2 | 29961574 | |
| Pubmed | Proneural genes define ground-state rules to regulate neurogenic patterning and cortical folding. | 1.26e-04 | 20 | 29 | 2 | 34407390 | |
| Pubmed | 1.53e-04 | 22 | 29 | 2 | 35245678 | ||
| Pubmed | 1.53e-04 | 22 | 29 | 2 | 28334989 | ||
| Pubmed | 1.53e-04 | 22 | 29 | 2 | 15496443 | ||
| Pubmed | 1.58e-04 | 126 | 29 | 3 | 16284245 | ||
| Pubmed | Slit/Robo signaling modulates the proliferation of central nervous system progenitors. | 1.68e-04 | 23 | 29 | 2 | 23083737 | |
| Pubmed | Stage-specific changes in gene expression in acutely isolated mouse CNS progenitor cells. | 2.15e-04 | 26 | 29 | 2 | 15890332 | |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 2.15e-04 | 26 | 29 | 2 | 34189436 | |
| Pubmed | 2.33e-04 | 27 | 29 | 2 | 35894043 | ||
| Pubmed | ISL1 is necessary for auditory neuron development and contributes toward tonotopic organization. | 2.50e-04 | 28 | 29 | 2 | 36074819 | |
| Pubmed | 2.88e-04 | 30 | 29 | 2 | 21880902 | ||
| Pubmed | 3.08e-04 | 31 | 29 | 2 | 32499648 | ||
| Pubmed | MLL4 is required after implantation, whereas MLL3 becomes essential during late gestation. | 3.49e-04 | 33 | 29 | 2 | 32439762 | |
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 4.39e-04 | 37 | 29 | 2 | 34323105 | |
| Pubmed | 5.39e-04 | 41 | 29 | 2 | 22675208 | ||
| Pubmed | 5.87e-04 | 197 | 29 | 3 | 36604605 | ||
| Pubmed | Hundreds of variants clustered in genomic loci and biological pathways affect human height. | 5.95e-04 | 198 | 29 | 3 | 20881960 | |
| Pubmed | 6.59e-04 | 205 | 29 | 3 | 20436479 | ||
| Pubmed | 8.02e-04 | 50 | 29 | 2 | 23658023 | ||
| Cytoband | 7q36.1 | 1.01e-03 | 74 | 29 | 2 | 7q36.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q36 | 4.55e-03 | 159 | 29 | 2 | chr7q36 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q25 | 5.01e-03 | 167 | 29 | 2 | chr1q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q42 | 1.01e-02 | 240 | 29 | 2 | chr1q42 | |
| GeneFamily | Netrins | 1.10e-05 | 6 | 16 | 2 | 661 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.54e-04 | 27 | 16 | 2 | 47 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.05e-04 | 34 | 16 | 2 | 487 | |
| GeneFamily | PHD finger proteins | 2.81e-03 | 90 | 16 | 2 | 88 | |
| Coexpression | NABA_MATRISOME | PAPPA2 PCSK5 NTNG1 SLIT2 ADAM29 NTNG2 FBN1 ADAMDEC1 ADAMTS3 SSPOP ADAM22 TNN LAMA1 | 1.43e-11 | 1008 | 29 | 13 | MM17056 |
| Coexpression | NABA_MATRISOME | PAPPA2 PCSK5 NTNG1 SLIT2 ADAM29 NTNG2 FBN1 ADAMDEC1 ADAMTS3 SSPOP ADAM22 TNN LAMA1 | 1.78e-11 | 1026 | 29 | 13 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.33e-09 | 191 | 29 | 7 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.59e-09 | 196 | 29 | 7 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 1.46e-08 | 270 | 29 | 7 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.66e-08 | 275 | 29 | 7 | M5884 | |
| Coexpression | NABA_ECM_REGULATORS | 2.10e-07 | 238 | 29 | 6 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 2.31e-07 | 242 | 29 | 6 | MM17062 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.17e-05 | 40 | 29 | 3 | M5887 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.33e-04 | 738 | 29 | 6 | MM17058 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.47e-04 | 751 | 29 | 6 | M5885 | |
| Coexpression | WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP | 2.00e-04 | 19 | 29 | 2 | M12084 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.30e-06 | 310 | 29 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.24e-06 | 336 | 29 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 2.20e-05 | 122 | 29 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.43e-05 | 125 | 29 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.71e-05 | 265 | 29 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 4.46e-05 | 146 | 29 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 5.77e-05 | 156 | 29 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 7.17e-05 | 165 | 29 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 7.50e-05 | 793 | 29 | 7 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.05e-04 | 182 | 29 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.07e-04 | 354 | 29 | 5 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 1.22e-04 | 364 | 29 | 5 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.62e-04 | 14 | 29 | 2 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.72e-04 | 207 | 29 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.29e-04 | 223 | 29 | 4 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 2.32e-04 | 418 | 29 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 2.57e-04 | 967 | 29 | 7 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | 2.57e-04 | 967 | 29 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | 2.59e-04 | 968 | 29 | 7 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 2.62e-04 | 429 | 29 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | 2.65e-04 | 972 | 29 | 7 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.66e-04 | 232 | 29 | 4 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | 2.89e-04 | 986 | 29 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#5_top-relative-expression-ranked_100 | 3.04e-04 | 19 | 29 | 2 | gudmap_developingKidney_e14.5 whole kidney - wildtype_100_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.48e-04 | 249 | 29 | 4 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.41e-04 | 747 | 29 | 6 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 5.11e-04 | 768 | 29 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | 5.29e-04 | 773 | 29 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.78e-04 | 120 | 29 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.02e-04 | 288 | 29 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#1 | 6.81e-04 | 127 | 29 | 3 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K1 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_200 | 8.71e-04 | 32 | 29 | 2 | gudmap_developingKidney_e14.5 whole kidney - wildtype_200_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.08e-03 | 337 | 29 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | 1.21e-03 | 905 | 29 | 6 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.24e-03 | 350 | 29 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 1.32e-03 | 356 | 29 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 1.34e-03 | 357 | 29 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 1.39e-03 | 361 | 29 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 1.45e-03 | 165 | 29 | 3 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#4_top-relative-expression-ranked_200 | 1.50e-03 | 42 | 29 | 2 | gudmap_developingKidney_e15.5_S-shaped body_200_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.53e-03 | 168 | 29 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#3_top-relative-expression-ranked_500 | 1.64e-03 | 44 | 29 | 2 | gudmap_developingKidney_e15.5_Proximal Tubules_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | 1.69e-03 | 967 | 29 | 6 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.77e-03 | 177 | 29 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | 1.78e-03 | 976 | 29 | 6 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 1.82e-03 | 388 | 29 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | 1.85e-03 | 390 | 29 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.12e-09 | 200 | 29 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.75e-07 | 199 | 29 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.80e-07 | 200 | 29 | 5 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 137 | 29 | 4 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 137 | 29 | 4 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-06 | 168 | 29 | 4 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-06 | 171 | 29 | 4 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_MEMP|lymph-node_spleen / Manually curated celltypes from each tissue | 4.98e-06 | 176 | 29 | 4 | 23a8ec42ebd42c539865a12d09773af90f3f8848 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.56e-06 | 181 | 29 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.94e-06 | 184 | 29 | 4 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.33e-06 | 187 | 29 | 4 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.46e-06 | 188 | 29 | 4 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.60e-06 | 189 | 29 | 4 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.88e-06 | 191 | 29 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.88e-06 | 191 | 29 | 4 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.88e-06 | 191 | 29 | 4 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.02e-06 | 192 | 29 | 4 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.02e-06 | 192 | 29 | 4 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.02e-06 | 192 | 29 | 4 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.17e-06 | 193 | 29 | 4 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 7.17e-06 | 193 | 29 | 4 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 7.17e-06 | 193 | 29 | 4 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.17e-06 | 193 | 29 | 4 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.17e-06 | 193 | 29 | 4 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.32e-06 | 194 | 29 | 4 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.32e-06 | 194 | 29 | 4 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.32e-06 | 194 | 29 | 4 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.32e-06 | 194 | 29 | 4 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.47e-06 | 195 | 29 | 4 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.47e-06 | 195 | 29 | 4 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.77e-06 | 197 | 29 | 4 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.77e-06 | 197 | 29 | 4 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.77e-06 | 197 | 29 | 4 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.93e-06 | 198 | 29 | 4 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.93e-06 | 198 | 29 | 4 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.93e-06 | 198 | 29 | 4 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.09e-06 | 199 | 29 | 4 | 30ab0750d51f168b18c434c974d24a4e70f29cc7 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.09e-06 | 199 | 29 | 4 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.25e-06 | 200 | 29 | 4 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.25e-06 | 200 | 29 | 4 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 8.25e-06 | 200 | 29 | 4 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 8.25e-06 | 200 | 29 | 4 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 8.25e-06 | 200 | 29 | 4 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.25e-06 | 200 | 29 | 4 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.11e-05 | 118 | 29 | 3 | 9f1d744f46d79ff2ab7f168f54fdbd9f4640dddd | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.43e-05 | 126 | 29 | 3 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Slco2a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.72e-05 | 133 | 29 | 3 | 9d7a08170d38ae9b2ff10a0fa505aeb3aae2824d | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.92e-05 | 134 | 29 | 3 | cb676d5bbc468bd3ce1b6712d41c986ee9221ac5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 140 | 29 | 3 | e16e31d6310347f1fe72051dd0d7650d090e6d3c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-04 | 140 | 29 | 3 | 7cc891d676555609add6fc7880735d948a2ad801 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Krt80|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.04e-04 | 141 | 29 | 3 | 40ef6d792e11fe10963d64eb0b606b90556c1a70 | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.30e-04 | 152 | 29 | 3 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 153 | 29 | 3 | 9b6675ace8a83c8d446b722301d0ec4e6840f3fc | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.35e-04 | 154 | 29 | 3 | 511923b27469ea20f8bd82a9ec27119a6e884644 | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 1.40e-04 | 156 | 29 | 3 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.42e-04 | 157 | 29 | 3 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.45e-04 | 158 | 29 | 3 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 159 | 29 | 3 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 159 | 29 | 3 | aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 159 | 29 | 3 | 8bbdef1e927f3130b578d7d7c5ff38bbe06fab63 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.53e-04 | 161 | 29 | 3 | 048b7dc00746987a24bf870d4d278c4183eb04a2 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.53e-04 | 161 | 29 | 3 | ba7ce599b173cf81c8323e7c96dc3d57379f1ed6 | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.62e-04 | 164 | 29 | 3 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 167 | 29 | 3 | 8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 168 | 29 | 3 | 4e2e4c88ada772e9ba6e72c9ae3a05c063e93318 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 168 | 29 | 3 | ee4dab089adef2f47a9d39d91934523331a8b81c | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-04 | 169 | 29 | 3 | 47fd4adfe54777e69a0fabf8bd34f26223f63275 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-04 | 169 | 29 | 3 | e09259d62cd3e42f0919f231ed1164db59b0b6c3 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-04 | 169 | 29 | 3 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-04 | 171 | 29 | 3 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 175 | 29 | 3 | 91cb819a1786020713b7e64480de0545380daae9 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 175 | 29 | 3 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-04 | 176 | 29 | 3 | 03d194c9814e12802cd932afade69e868814cb78 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-04 | 176 | 29 | 3 | cd4b9211652596c42e7af318bcd464681daebb10 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 177 | 29 | 3 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.13e-04 | 180 | 29 | 3 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 2.13e-04 | 180 | 29 | 3 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.13e-04 | 180 | 29 | 3 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-04 | 181 | 29 | 3 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 181 | 29 | 3 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 181 | 29 | 3 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-04 | 181 | 29 | 3 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 181 | 29 | 3 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-04 | 182 | 29 | 3 | 1647367b75b4b107af06bb934394168230cfd7c2 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 182 | 29 | 3 | b8be66a867ea1bbae0820b26dbd55b68611f5ad5 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 182 | 29 | 3 | cb488f9a9b200e2557335ccf22535cd247512cdc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 184 | 29 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 184 | 29 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 184 | 29 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 184 | 29 | 3 | fea4fe648e9749177d0783443dc26a7df5807883 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 184 | 29 | 3 | 96a8a0a190bc293655fe7d80cbed8119c0da25f2 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 184 | 29 | 3 | 780eb72da43527f0c72effac3423ec7384f05f20 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.27e-04 | 184 | 29 | 3 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.31e-04 | 185 | 29 | 3 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 2.31e-04 | 185 | 29 | 3 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.38e-04 | 187 | 29 | 3 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-04 | 187 | 29 | 3 | 8bd635abdee5d5a12a3f7bf74eab4282e8e40741 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.38e-04 | 187 | 29 | 3 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-04 | 187 | 29 | 3 | 3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.38e-04 | 187 | 29 | 3 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| Drug | Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 4.62e-06 | 197 | 29 | 5 | 6830_UP | |
| Drug | Azlocillin sodium salt [37091-65-9]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 4.86e-06 | 199 | 29 | 5 | 6262_UP | |
| Drug | Ellipticine [519-23-3]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 8.37e-05 | 184 | 29 | 4 | 2758_UP | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A | 8.91e-05 | 187 | 29 | 4 | 6975_UP | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 1.01e-04 | 193 | 29 | 4 | 3296_UP | |
| Drug | Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.03e-04 | 194 | 29 | 4 | 4182_UP | |
| Drug | Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.05e-04 | 195 | 29 | 4 | 4019_DN | |
| Drug | Fluspirilen [1841-19-6]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.05e-04 | 195 | 29 | 4 | 5008_DN | |
| Drug | Atovaquone [95233-18-4]; Up 200; 11uM; HL60; HT_HG-U133A | 1.05e-04 | 195 | 29 | 4 | 2480_UP | |
| Drug | Tranexamic acid [1197-18-8]; Down 200; 25.4uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 2248_DN | |
| Drug | Estriol [50-27-1]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 3563_UP | |
| Drug | F0447-0125; Up 200; 10uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 6396_UP | |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 6615_DN | |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 3380_UP | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 1819_DN | |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 3431_UP | |
| Drug | Piperidolate hydrochloride [129-77-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 3551_UP | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 6829_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 3708_DN | |
| Drug | Deoxycorticosterone [64-85-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 6476_UP | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 2054_DN | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 6635_UP | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 6031_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 3707_DN | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 3700_DN | |
| Drug | Lisuride (S)(-) [18016-80-3]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 6682_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 4016_DN | |
| Drug | Riboflavine [83-88-5]; Up 200; 10.6uM; PC3; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 4485_UP | |
| Disease | netrin-G1 measurement | 2.80e-06 | 3 | 29 | 2 | EFO_0801825 | |
| Disease | radiation-induced disorder | 3.92e-05 | 67 | 29 | 3 | EFO_0009565 | |
| Disease | response to bisphosphonate, osteonecrosis | 4.18e-05 | 10 | 29 | 2 | EFO_0004259, EFO_0009958 | |
| Disease | Colorectal Carcinoma | 5.28e-05 | 702 | 29 | 6 | C0009402 | |
| Disease | Intellectual Disability | 6.86e-05 | 447 | 29 | 5 | C3714756 | |
| Disease | Abnormal behavior | 1.11e-04 | 16 | 29 | 2 | C0233514 | |
| Disease | blood cobalt measurement | 1.33e-04 | 101 | 29 | 3 | EFO_0007577 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 1.58e-04 | 19 | 29 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | body weight | 1.75e-04 | 1261 | 29 | 7 | EFO_0004338 | |
| Disease | blood nickel measurement | 2.22e-04 | 120 | 29 | 3 | EFO_0007583 | |
| Disease | Postural instability | 2.76e-04 | 25 | 29 | 2 | HP_0002172 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 6.08e-04 | 37 | 29 | 2 | DOID:0050545 (implicated_via_orthology) | |
| Disease | cortical thickness | 6.40e-04 | 1113 | 29 | 6 | EFO_0004840 | |
| Disease | oral microbiome measurement | 7.84e-04 | 42 | 29 | 2 | EFO_0801229 | |
| Disease | cortical surface area measurement | 1.71e-03 | 1345 | 29 | 6 | EFO_0010736 | |
| Disease | serum gamma-glutamyl transferase measurement | 1.80e-03 | 914 | 29 | 5 | EFO_0004532 | |
| Disease | pulse pressure measurement | 2.03e-03 | 1392 | 29 | 6 | EFO_0005763 | |
| Disease | anorexia nervosa | 2.16e-03 | 70 | 29 | 2 | MONDO_0005351 | |
| Disease | Manic Disorder | 2.22e-03 | 71 | 29 | 2 | C0024713 | |
| Disease | pentachlorophenol measurement | 2.35e-03 | 73 | 29 | 2 | EFO_0022071 | |
| Disease | parathion measurement | 2.35e-03 | 73 | 29 | 2 | EFO_0022070 | |
| Disease | potassium chromate measurement | 2.35e-03 | 73 | 29 | 2 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 2.35e-03 | 73 | 29 | 2 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 2.35e-03 | 73 | 29 | 2 | EFO_0022067 | |
| Disease | methoxychlor measurement | 2.35e-03 | 73 | 29 | 2 | EFO_0022069 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEGEECDCGPLKHCA | 406 | Q9UKF5 | |
| EDGHCSIKDCHVEPC | 86 | Q86YB8 | |
| EECDCGTPAECVLEG | 456 | Q9P0K1 | |
| KCCFCHEEGDGLTDG | 4401 | Q8NEZ4 | |
| KNKAGPECLHCEEGC | 691 | Q6ZNB6 | |
| DEEDRGCCCCKPGHL | 1466 | A6NKB5 | |
| VEEDEGCCCCEPGHL | 1421 | Q9H6A9 | |
| CHKDCLECSGPKADD | 1371 | Q92824 | |
| HGECKWPGCETLCED | 306 | Q8IVH2 | |
| CVPLSGKCDGHEDCI | 1916 | Q5VYJ5 | |
| GKCDGHEDCIDGSDE | 1921 | Q5VYJ5 | |
| CEPSKIGNDHCDPEC | 586 | Q9BXP8 | |
| GDHCDGEKPESVRAC | 996 | O15072 | |
| CLPGCDEQHGFCDKP | 226 | O00548 | |
| DEQHGFCDKPGECKC | 231 | O00548 | |
| GECIDVDECEKNPCA | 486 | P35555 | |
| GAKDCACSCHEGGPD | 1846 | Q3T8J9 | |
| ECEHNTTGPDCGKCK | 316 | Q9Y2I2 | |
| ECEHNTTGPDCGKCK | 306 | Q96CW9 | |
| FCECREGAAGPKCDD | 426 | Q96CW9 | |
| ECAPACGQHCGKPED | 836 | A2VEC9 | |
| CPPHTQGVKCEECED | 1016 | P25391 | |
| EHVGSGLECPVCKDD | 221 | Q9BV68 | |
| TEHGQCKDGKCECSP | 731 | Q9UKZ4 | |
| EHGTCKDGKCECREG | 776 | Q9NT68 | |
| HLLEVGEDCDCGSPK | 426 | O15204 | |
| GEDCDCGSPKECTNL | 431 | O15204 | |
| EICDNACPCEEKDGI | 46 | O94991 | |
| EDCSEKRCPGDCSGH | 226 | Q9UQP3 | |
| KCLEGHGGVLCDEEE | 1396 | O94813 | |
| GDSLIPCEGECCKHF | 711 | Q9BZ95 | |
| CPDGDKCRCAHGQEE | 901 | Q9UGR2 | |
| ESPCGDCGDCHPLEL | 191 | Q8NAP8 |